FDA Approved: YONDELIS — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for YONDELIS (trabectedin) from Janssen Products, LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Yondelis (trabectedin)

Snippet

SUPPL AP for YONDELIS (TRABECTEDIN)